Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant

Yanal Alnimer, Murad Aldarayseh, Hiffsa Taj, Zena Chahine, Reinhold Munker, Gregory Monohan, Chaitanya Iragavarapu, Fevzi Yalniz, Ayman Qasrawi

Blood (2025) 146 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2025-2442

Published: 2025

Journal Articles

CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel

Ross McCauley, Amy Zhang, Vamsi Kota, Jacob Boccucci, Michael Grunwald, Matthew Ulrickson, LaQuisa Hill, Ibrahim Muhsen, Joshua Sasine, Anjali Advani, Ibrahim Aldoss, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Silvina Odstrcil Bobillo, Stephanie Tsai, Talal Hilal, Bijal Shah, Rawan Faramand, Jae Park, Yannis Valtis, Tamer Othman, Sumithira Vasu, Evandro Bezerra, Jessica Leonard, Virginia Tan, Kristen O'Dwyer, Jozal Moore, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Wendy Stock, Caspian Oliai, Georgia Lill, Marc Schwartz, Divya Koura, Kaitlyn Dykes, Aaron Logan, Michael Daunov, Ken Byrd, Fevzi Yalniz, Noelle Frey, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Ali Al-Darobi, Evan Chen, Catherine Lee, Timothy O'Connor, Bhagirathbhai Dholaria, Veronika Bachanova, Sean Tracy, Hrishikesh Srinagesh, Katharine Miller, Katherine Sutherland, Navneet Majhail, Luke Mountjoy, Shahbaz Malik, Aravind Ramakrishnan, Paul Shaughnessy, John Mathews, Eunice Wang, Minoo Battiwalla, Gregory Roloff, Lori Muffly

Blood (2025) 146 (Supplement 1): 2396.

https://doi.org/10.1182/blood-2025-2396

Published: 2025

Journal Articles

Beyond age: Genomic features and treatment outcomes in older versus younger adults with Acute Myeloid Leukemia

Hardik Dand, Yanal Alnimer, Rafeh Safdar, Jonah Heidel, Cole Blanford, Chandra Kakarala, Ayman Qasrawi, Gregory Monohan, Reinhold Munker, Chaitanya Iragavarapu, Zena Chahine, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 3380.

https://doi.org/10.1182/blood-2025-3380

Published: 2025

Journal Articles

KMT2Ar, but not other high-risk genetics, adversely impacts outcomes in adult patients with relapsed/refractory (R/R) Philadelphia chromosome negative B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel (Brexu-cel)

Jessica Leonard, Abdullah Ladha, Rawan Faramand, Gregory Roloff, Yannis Valtis, Virginia Tan, Katharine Miller, Amy Zhang, Michael Grunwald, Vamsi Kota, Jacob Boccucci, Matthew Ulrickson, Ali Al-Darobi, LaQuisa Hill, Ibrahim Muhsen, Joshua Sasine, Anjali Advani, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Evan Chen, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Catherine Lee, Silvina Odstrcil Bobillo, Stephanie Tsai, Timothy O'Connor, Talal Hilal, Jae Park, Sumithira Vasu, Evandro Bezerra, Kristen O'Dwyer, Jozal Moore, Eunice Wang, Ross McCauley, Navneet Majhail, Aravind Ramakrishnan, Luke Mountjoy, Shahbaz Malik, Minoo Battiwalla, Paul Shaughnessy, John Mathews, Hrishikesh Srinagesh, Katherine Sutherland, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Caspian Oliai, Georgia Lill, Wendy Stock, Marc Schwartz, Tamer Othman, Divya Koura, Kaitlyn Dykes, Aaron Logan, Michael Daunov, Ken Byrd, Fevzi Yalniz, Veronika Bachanova, Sean Tracy, Punita Grover, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Bhagirathbhai Dholaria, Noelle Frey, Lori Muffly, Bijal Shah, Ibrahim Aldoss

Blood (2025) 146 (Supplement 1): 3365.

https://doi.org/10.1182/blood-2025-3365

Published: 2025

Journal Articles

Outcomes with liposomal daunorubicin/cytarabine – a single-center experience

Jonah Heidel, Rafeh Safdar, Cole Blanford, Chandra Kakarala, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 6973.

https://doi.org/10.1182/blood-2025-6973

Published: 2025

Journal Articles

Genetic risk model to predict outcomes for AML treated with HMA and venetoclax

Rafeh Safdar, Chandra Kakarala, Jonah Heidel, Cole Blanford, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 1708.

https://doi.org/10.1182/blood-2025-1708

Published: 2025

Journal Articles

Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia

Cole Blanford, Rafeh Safdar, Jonah Heidel, Chandra Kakarala, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 1729.

https://doi.org/10.1182/blood-2025-1729

Published: 2025

Journal Articles

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes

Yanal Alnimer, Rafeh Safdar, Hardik Dand, Cole Blanford, Jonah Heidel, Kakrala Chandra, Zena Chahine, Chaitanya Iragavarapu, Gregory Monohan, Reinhold Munker, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 7034.

https://doi.org/10.1182/blood-2025-7034

Published: 2025

Journal Articles

Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world

Aaron Logan, Fevzi Yalniz, Amy Zhang, Katharine Miller, Katherine Sutherland, Nikeshan Jeyakumar, Hrishikesh Srinagesh, Michael Grunwald, Vamsi Kota, Jacob Boccucci, Matthew Ulrickson, Ali Al-Darobi, Joshua Sasine, LaQuisa Hill, Ibrahim Muhsen, Anjali Advani, Ibrahim Aldoss, Tamer Othman, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Evan Chen, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Catherine Lee, Silvina Odstrcil Bobillo, Stephanie Tsai, Timothy O'Connor, Talal Hilal, Jae Park, Yannis Valtis, Sumithira Vasu, Evandro Bezerra, Eunice Wang, Jessica Leonard, Virginia Tan, Kristen O'Dwyer, Jozal Moore, Ross McCauley, Navneet Majhail, Luke Mountjoy, Aravind Ramakrishnan, Shahbaz Malik, Minoo Battiwalla, Paul Shaughnessy, John Mathews, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Wendy Stock, Gregory Roloff, Caspian Oliai, Georgia Lill, Marc Schwartz, Divya Koura, Kaitlyn Dykes, Michael Daunov, Ken Byrd, Veronika Bachanova, Sean Tracy, Punita Grover, Noelle Frey, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Bhagirathbhai Dholaria, Rawan Faramand, Lori Muffly

Blood (2025) 146 (Supplement 1): 516.

https://doi.org/10.1182/blood-2025-516

Published: 2025

Journal Articles

Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia

Sarah Sertich, Brent Harris, Yanal Alnimer, Rafeh Safdar, Gregory Monohan, Zena Chahine, Reinhold Munker, Chaitanya Iragavarapu, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 3454.

https://doi.org/10.1182/blood-2025-3454

Published: 2025

Journal Articles

Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome

Yanal Alnimer, Reinhold Munker, Ayman Qasrawi, Gregory Monohan, Chait Iragavarapu, Fevzi Yalniz

Blood (2024) 144 (Supplement 1): 4605.

https://doi.org/10.1182/blood-2024-210157

Published: 2024

Journal Articles

Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

Yanal Alnimer, Fevzi Yalniz, Gregory Monohan, Reinhold Munker, Ayman Qasrawi, Chait Iragavarapu, Mahmoud Amr

Blood (2024) 144 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2024-211992

Published: 2024

Journal Articles

Efficacy of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm, an Interrupted Time Series Analysis

Yanal Alnimer, Moaath K. Mustafa Ali, Ayman Qasrawi, Fevzi Yalniz, Gregory Monohan, Chait Iragavarapu

Blood (2024) 144 (Supplement 1): 6016.

https://doi.org/10.1182/blood-2024-212229

Published: 2024

Journal Articles

A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia between Appalachian and Non-Appalachian Kentucky

Zena Chahine, Xitong Zhou, Anna Johnson, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Chaitanya Iragavarapu, Gregory Monohan, Reinhold Munker, Fevzi Yalniz, Ayman Qasrawi, Reshma Ramlal

Blood (2023) 142 (Supplement 1): 5864.

https://doi.org/10.1182/blood-2023-185356

Published: 2023

Journal Articles

Correlation between Number of Molecular Mutations and Outcomes in De Novo Acute Myeloid Leukemia

Zena Chahine, Xitong Zhou, Anna Johnson, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Chaitanya Iragavarapu, Reinhold Munker, Gregory Monohan, Fevzi Yalniz, Ayman Qasrawi, Reshma Ramlal

Blood (2023) 142 (Supplement 1): 5878.

https://doi.org/10.1182/blood-2023-188007

Published: 2023

Journal Articles

Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study

Anna Johnson, Zena Chahine, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Xitong Zhou, Chaitanya Iragavarapu, Reinhold Munker, Gregory Monohan, Reshma Ramlal, Ayman Qasrawi, Fevzi Yalniz

Blood (2023) 142 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2023-189764

Published: 2023

Journal Articles

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

Dominik Dytfeld, Binod Dhakal, Mounzer Agha, Salomon Manier, Michel Delforge, Steven Kuppens, Salma Afifi, William Deraedt, Agne Taraseviciute-Morris, Jordan M. Schecter, Jane Gilbert, Fevzi Yalniz, Erika Florendo, Lida Pacaud, Vania Hungria, Saad Z. Usmani, Maria-Victoria Mateos

Blood (2021) 138 (Supplement 1): 1835.

https://doi.org/10.1182/blood-2021-146210

Published: 2021

Journal Articles

Prognostic Significance of Baseline FLT3 -ITD Mutant Allele Burden in Acute Myeloid Leukemia Treated with Intensive Chemotherapy with/without Sorafenib

Fevzi Yalniz, Hagop M. Kantarjian, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Keyur Patel, MD PhD, Sanam Loghavi, MD, Koji Sasaki, MD, Naval G. Daver, MD, Courtney D. DiNardo, MD MSc, Naveen Pemmaraju, MD, Nicholas J Short, MD, Musa Yilmaz, MD, Prithviraj Bose, MD, Kiran Naqvi, MD MPH, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Farhad Ravandi, MD

Blood (2018) 132 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2018-99-117692

Published: 2018

Journal Articles

Potential Predictors of Induction Failure and Complete Remission Duration in FLT3 -ITD Mutated Acute Myeloid Leukemia

Fevzi Yalniz, Hagop M. Kantarjian, MD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Naval G. Daver, MD, Naveen Pemmaraju, MD, Marina Y. Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Koichi Takahashi, MD, Courtney D. DiNardo, MD MSc, Prithviraj Bose, MD, Michael Andreeff, MD PhD, Farhad Ravandi, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3996.

https://doi.org/10.1182/blood-2018-99-119928

Published: 2018

Journal Articles

Prognostic Factors and Survival Outcomes in Blast Transformed Chronic Myelomonocytic Leukemia: A Mayo Clinic-MD Anderson Cancer Center Study of 171 Cases

Mrinal M. Patnaik, MDMBBS, Ana Alfonso, MD, Fevzi Yalniz, MD, Tapan M. Kadia, MD, Rangit Vallapureddy, MBBS, Elias Jabbour, MD, Terra L. Lasho, PhD, Curtis A. Hanson, MD, Hagop M. Kantarjian, MD, Ayalew Tefferi, MD, Guillermo Garcia-Manero, MD

Blood (2017) 130 (Supplement 1): 2964.

https://doi.org/10.1182/blood.V130.Suppl_1.2964.2964

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant

CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel

Beyond age: Genomic features and treatment outcomes in older versus younger adults with Acute Myeloid Leukemia

KMT2Ar, but not other high-risk genetics, adversely impacts outcomes in adult patients with relapsed/refractory (R/R) Philadelphia chromosome negative B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel (Brexu-cel)

Outcomes with liposomal daunorubicin/cytarabine – a single-center experience

Genetic risk model to predict outcomes for AML treated with HMA and venetoclax

Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes

Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world

Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia

Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome

Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

Efficacy of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm, an Interrupted Time Series Analysis

A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia between Appalachian and Non-Appalachian Kentucky

Correlation between Number of Molecular Mutations and Outcomes in De Novo Acute Myeloid Leukemia

Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

Prognostic Significance of Baseline FLT3 -ITD Mutant Allele Burden in Acute Myeloid Leukemia Treated with Intensive Chemotherapy with/without Sorafenib

Potential Predictors of Induction Failure and Complete Remission Duration in FLT3 -ITD Mutated Acute Myeloid Leukemia

Prognostic Factors and Survival Outcomes in Blast Transformed Chronic Myelomonocytic Leukemia: A Mayo Clinic-MD Anderson Cancer Center Study of 171 Cases

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only